Who invested in Lassen Therapeutics?
Lassen Therapeutics's investors include Catalio Capital Management, Longitude Capital and Longwood Fund.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$85Mraised across 1 round since 2023, from 1 source
Lassen Therapeutics's investors include Catalio Capital Management, Longitude Capital and Longwood Fund.
Lassen Therapeutics has raised $85M across 1 round since 2023.
Lassen Therapeutics's most recent round was a Series B of $85M in Dec 2023.
Its most recent round, $85M in Dec 2023, is also its largest on record.
Lassen Therapeutics's first round on record, in Dec 2023, was backed by Catalio Capital Management, Longitude Capital and Longwood Fund.
Lassen Therapeutics's latest named round is a Series B, in Dec 2023.
Lassen Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.